COVIDOSE: Determining infectious dose for SARS-CoV-2 and assessing contact/proximity risk

  • Funded by Research Council of Norway (RCN)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $471,240
  • Funder

    Research Council of Norway (RCN)
  • Principle Investigator

    Pending
  • Research Location

    Norway, Europe
  • Lead Research Institution

    UNIVERSITETET I OSLO
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVIDOSE project has a goal-oriented and straightforward approach to its first and main goal: determining the infectious dose, i.e. the minimum number of SARS-CoV-2 virus particles needed to start an infection resulting in disease, achieved through coalescent analysis on population-based viral genomics sampled from Norwegian patients. Furthermore, this will be compared to samples from likely contact points in the environment to contribute to risk assessment and transmission dynamics. Lastly, an innovative outreach plan enables an open platform for our research. It draws on a small, dedicated team of specialists well placed for such a study. The team consists of highly creative,ambitious and talented researchers in established yet highly productive career stages with the ability, experience and drive to accomplish our objectives. Our work is highly visible and has been featured in Nature, Science, PNAS, Nature Communications, Nature Ecology & Evolution, among other top journals.